Healthcare >> CEO Interviews >> May 13, 2003

Alan Smith – Genzyne Corporation

ALAN E. SMITH is Senior Vice President, Research and Chief Scientific Officer at Genzyme Corporation and has overall responsibility for the company's science. Before Integrated Genetics was acquired by Genzyme in 1989, Dr. Smith held the position of Vice President and Scientific Director at IG. Prior to joining IG in 1984, Dr. Smith was head of the Biochemistry Division of the National Institute for Medical Research, Mill Hill, London, England. Previous to that, he was a member of the scientific staff of the Imperial Cancer Research Fund, London, England. Dr. Smith has authored and co-authored over 180 publications in the areas of biochemistry, virology, molecular biology and gene therapy. He received his Bachelor of Arts degree in Biochemistry from Christ's College, Cambridge, England and holds a Doctor of Philosophy degree from the Laboratory of Molecular Biology, Cambridge, England. Profile
TWST: Would you begin with a broad brush of what you see going on

in biotech at the moment?

Dr. Smith: Francis Collins has just announced the completion of

the goals in the Human Genome